Q3 2024 Collegium Pharmaceutical Inc Earnings Call Transcript

Author's Avatar
Nov 08, 2024

Nov 07, 2024 / 09:30PM GMT
Operator

Greetings, and welcome to the Collegium Pharmaceutical third quarter 2024 earnings conference call. (Operator Instructions) Please note that this conference call is being recorded.

I will now turn the call over to Danielle Jesse, Director of Investor Relations at Collegium. Please go ahead.

Danielle Jesse - Collegium Pharmaceutical Inc - Director, Investor Relations

Welcome to Collegium Pharmaceuticals third quarter 2024 earnings conference call. I am joined today by Mike Heffernan, our Interim President and Chief Executive Officer, Founder and Chairman; Colleen Tupper, our Chief Financial Officer; and Scott Dreyer, our Chief Commercial Officer.

Before we begin today's call, we want to remind participants that none of the information presented today is intended to be promotional, and that any forward-looking statements made today are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995. You are cautioned that such forward-looking statements involve risks and uncertainties, including and without

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot